N-terminal-pro–B-type natriuretic peptide improved risk prediction and classification compared with the Framingham Risk Score and the Pooled Cohort Risk Equation. Change in NT-proBNP was independently associated with events. None of the observed associations varied by ethnicity.
Both NT-proBNP and TnT are predictors of incident CHD, independent of established risk factors and ethnicity, in a multiethnic population without known CVD. Change in NT-proBNP may add additional prognostic information.
Read more:
NT-proBNP and Cardiac Troponin T for CVD Risk Assessment
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhA5QwflyliMTEkVD8zRdS5vM5nGSzha7_Sj9MYQbhkuok6o58dEwn5rK2dkel_Pahkg-ttZrzxRAI563SB_EeXiCLO2zpzbcnHury1QehqfCnC18YkjT87oelJkbqfWK44iD39fJPM7Sg/s400/002.jpg)
Image credits: Nature Clinical Practice
No comments:
Post a Comment